| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Girentuximab | MAb-G250; cG250; WX-G250 | Phase 3 Clinical | Wilex AG | Carcinoma, Renal Cell; Kidney Neoplasms | 詳細 |
| Girentuximab-Zr-89 | 89Zr-TX250; TLX-250-CDx; 89Zr-TX-250; TLX250-CDx; 89Zr-TLX250 | Phase 3 Clinical | Wilex AG | Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Cholangiocarcinoma; Colorectal Neoplasms; Contrast agents; Esophageal Neoplasms; Glioblastoma; Nasopharyngeal Carcinoma; Sarcoma; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; von Hippel-Lindau Disease | 詳細 |
| Lutetium-177 DOTA girentuximab | TLX-250 | Phase 2 Clinical | Heidelberg Pharma AG, Telix Pharmaceuticals Ltd, Wilex AG | Carcinoma, Renal Cell; Neoplasms | 詳細 |
| [177Lu]Lu-DPI-4452 | [177Lu]Lu-DPI-4452; Debio 0228; ITM-91; 3BP-4452; 177Lu-DPI-4452 | Phase 2 Clinical | 3B Pharmaceuticals GmbH | Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Head and Neck Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms | 詳細 |
| Debio-0328 | [68Ga]Ga-DPI-4452; Gallium-68-DPI-4452; ITM-94D; 68Ga-DPI-4452 | Phase 2 Clinical | 3B Pharmaceuticals GmbH | Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Head and Neck Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms | 詳細 |
| 68Ga-NY104 | 68Ga-NYM005; 68Ga-NY-104 | Phase 2 Clinical | Wuxi Nuoyu Pharmaceutical Technology Co Ltd | Carcinoma, Renal Cell | 詳細 |
| PMI-05 | PMI-05 | Phase 1 Clinical | Precision Molecular Inc | Neoplasms | 詳細 |
| PHC-102 | 99mTc-CAIX; PHC102; 99mTc-PHC-102 | Phase 1 Clinical | Philochem | Carcinoma, Renal Cell | 詳細 |
| Indium-111-DOTA-girentuximab-IRDye800CW | 111In-girentuximab-F2 | Phase 1 Clinical | Radboud University Nijmegen | Carcinoma, Renal Cell; Diagnostic agents | 詳細 |
| [211At]At-girentuximab | Phase 1 Clinical | ATONCO, Institut de Cancérologie de l'Ouest | Urinary Bladder Neoplasms | 詳細 | |
| [68Ga]Ga-OncoCAIX | 68Ga-OncoCAIX; [68Ga]Ga-OncoCAIX | Phase 1 Clinical | Philogen Spa | Carcinoma, Renal Cell | 詳細 |
| 18F-NY104 | 18F-NY104; 18F-NYM005 | Phase 1 Clinical | Wuxi Nuoyu Pharmaceutical Technology Co Ltd | Carcinoma, Renal Cell; Contrast agents | 詳細 |
| CA9hu-1 | CA9hu-1 | Phase 1 Clinical | Mabpro AS | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Head and Neck Neoplasms; Mesothelioma; Triple Negative Breast Neoplasms | 詳細 |
| Sulfamide-nitroimidazole | Clinical | Dualtpharma | Neoplasms | 詳細 | |
| 68Ga-C1 | Clinical | The First Affiliated Hospital Of Beijing University | Carcinoma, Renal Cell | 詳細 | |
| 64Cu-PD-32766 | 64Cu-PD-32766 | Clinical | PeptiDream Inc | Carcinoma, Renal Cell; Colorectal Neoplasms; Glioblastoma; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | 詳細 |